Accelerate Technologies Pte Ltd
Overview
Accelerate Technologies Pte Ltd is the commercialisation arm of Singapore's Agency for Science, Technology and Research (A*STAR), focused on translating scientific research and intellectual property into market-ready solutions through licensing, spin-offs, and venture co-creation.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Prefer | Feb 2024 | Seed | Co-investor |
| Nalagenetics | Mar 2022 | Series A | Co-investor |
| Sentient.io | Dec 2021 | Series B | Co-investor |
| Precision Diabetes, Inc. | Sep 2017 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Accelerate Technologies Pte Ltd based?
Accelerate Technologies Pte Ltd is headquartered in Singapore, Singapore.
When was Accelerate Technologies Pte Ltd founded?
Accelerate Technologies Pte Ltd was founded in 1995.
How many portfolio companies does Accelerate Technologies Pte Ltd have?
Accelerate Technologies Pte Ltd has 5 portfolio companies in Caplight's dataset.
What are some companies in Accelerate Technologies Pte Ltd's portfolio?
Recent investments visible on Caplight include Prefer, Nalagenetics, Sentient.io, Sentient.io, Precision Diabetes, Inc..
What was Accelerate Technologies Pte Ltd's most recent investment?
Accelerate Technologies Pte Ltd's most recent investment on Caplight was in Prefer in 2024.
What sectors does Accelerate Technologies Pte Ltd focus on?
Accelerate Technologies Pte Ltd focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does Accelerate Technologies Pte Ltd focus on?
Accelerate Technologies Pte Ltd typically invests at the Early stage.